Bulletin
Investor Alert

Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 7, 2020, 7:59 p.m.

/zigman2/quotes/209129655/composite

$

7.49

Change

+0.03 +0.40%

Volume

Volume 59,988

Quotes are delayed by 20 min

/zigman2/quotes/209129655/composite

Previous close

$ 7.76

$ 7.46

Change

-0.30 -3.87%

Day low

Day high

$7.28

$7.80

Open

52 week low

52 week high

$2.43

$46.25

Open

Mark Castaneda

Presently, Mark Castaneda is Head-Strategic Business Development at Tilray, Inc.

He previously occupied the position of Chief Financial Officer at Tecta America Corp., Chief Financial Officer & Secretary for Pike Corp. and Chief Financial Officer at Pike Electric LLC (a subsidiary of Pike Corp.), Chief Financial Officer of All Star Gas Corp., Chief Financial Officer & Director at Blue Rhino Corp., Chief Financial Officer & Assistant Treasurer at Primo Water Corp., Chief Financial Officer for Interact Public Safety Systems, Inc. and Principal at Deloitte & Touche LLP.

He received an undergraduate degree and a graduate degree from DePaul University.

Transactions

Date Shares Transaction Value
07/18/2019 78,700   Derivative/Non-derivative trans. at $43.41 per share. 3,416,367
07/18/2019 200,000   Derivative/Non-derivative trans. at $0 per share. 0
04/15/2019 10,000   Disposition at $51.72 per share. 517,200
04/15/2019 10,000   Derivative/Non-derivative trans. at $7.76 per share. 77,600
03/14/2019 30,000   Disposition at $70.43 per share. 2,112,900
03/14/2019 30,000   Derivative/Non-derivative trans. at $7.76 per share. 232,800
02/25/2019 900   Disposition at $79.38 per share. 71,442
02/25/2019 8,197   Disposition at $78.68 per share. 644,940
02/25/2019 30,903   Disposition at $77.89 per share. 2,407,035
02/25/2019 40,000   Derivative/Non-derivative trans. at $7.76 per share. 310,400
07/23/2018 6,500   Gift at $0 per share. 0
07/23/2018 14,705   Acquisition at $17 per share. 249,985

Officers and Executives

Mr. Brendan Kennedy
President, Chief Executive Officer & Director
Mr. Jon Levin
Chief Operating Officer
Mr. Michael Kruteck
Chief Financial Officer
Dr. Joshua Eades
Chief Science Officer & Vice President
Mr. Mark Castaneda
Head-Strategic Business Development
Mr. Edward Wood Pastorius
Chief Revenue Officer
Mr. Andrew Pucher
Chief Corporate Development Officer
Ms. Adine Fabiani-Carter
Chief Marketing Officer
Ms. Rita Seguin
Executive Vice President-Human Resources
Ms. Dara Redler
Secretary & General Counsel
Ms. Catherine Jacobson
VP-Regulatory & Medical Affairs
Ms. Christine Thompson St. Clare
Independent Director
Ms. Maryscott Greenwood
Independent Director
Ms. Rebekah Dopp
Independent Director
Mr. Michael Shtender-Auerbach
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.